Skip to content

CONMED CNMD Operating Cash Flow

Operating Cash Flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$2.51B-39.8%
Stryker logo
StrykerSYK
$581M+132%
Boston Scientific logo
Boston ScientificBSX
$348M-35.7%
Vericel logo
VericelVCEL
$16.38M+148%
OSI Systems logo
OSI SystemsOSIS
$14.46M-82.3%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$359.4M-6.1%

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.04B-35.6%
Enterprise value$1.87B-24.5%
P/E19×+5.4×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's operating cash flow?
CONMED (CNMD) reported operating cash flow of $13.47M in Q1 2026.
How has CONMED's operating cash flow changed year-over-year?
CONMED's operating cash flow decreased by 67.6% year-over-year, from $41.53M to $13.47M.
What is the long-term trend for CONMED's operating cash flow?
Over 3 years (2021 to 2025), CONMED's operating cash flow has grown at a 15.2% compound annual growth rate (CAGR), from $111.77M to $170.69M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.